Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astrazeneca, Biontech, China Oncology Focus, Clinuvel, Curevac, Eli Lilly, I-Mab, Immunitybio, Moderna, Nantkwest, Oxford University, Pfizer, Russian Direct Investment Fund, Sorrento, Takeda, Triastek, University of Oxford.